Celldex Therapeutics, Inc. CLDX
27.42 USD -0.54 (-1.93%)
Regular-session close
27.40 -0.02 -0.07%
After hours · Nov 20, 5:33 PM ET
26.64 Day range 28.43
22.58 52-week range 44.87
- YTD
- +0.96%
- 1 year
- +9.37%
Held by funds
120 US ETFs and mutual funds hold CLDX · largest positions
- VGHCX 0.43% of fund $163.31M
- VTI 0.00% of fund $81.31M
- IWM 0.08% of fund $57.95M
- NJM 0.07% of fund $53.07M
- XBI 0.46% of fund $48.31M
- VEXRX 0.21% of fund $47.17M
- FSSNX 0.10% of fund $33.92M
- FDSCX 0.46% of fund $33.87M
- FBIOX 0.52% of fund $30.83M
- ANOGX 0.50% of fund $29.52M
- VXF 0.03% of fund $28.80M
- ANOIX 0.50% of fund $25.71M
- FBTTX 0.90% of fund $21.10M
- NAJ 0.14% of fund $19.38M
- FIDGX 0.21% of fund $18.78M
- FSCRX 0.81% of fund $17.81M
- IWO 0.12% of fund $16.94M
- VTWO 0.08% of fund $14.73M
- DFAS 0.04% of fund $13.03M
- SCHA 0.05% of fund $11.97M
Ownership
Held by insiders 0.27%
Held by institutions 115.59%
Float held by institutions 115.90%
Institutions 335
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wellington Management Group, LLP | 13.58% | 10,671,399 | 292.61M | Sep 29, 2026 |
| FMR, LLC | 10.99% | 8,637,498 | 236.84M | Sep 29, 2026 |
| Blackrock Inc. | 8.84% | 6,948,371 | 190.52M | Sep 29, 2026 |
| Kynam Capital Management, LP | 6.45% | 5,066,051 | 138.91M | Sep 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.58% | 4,385,929 | 120.26M | Sep 29, 2026 |
| State Street Corporation | 4.43% | 3,478,549 | 95.38M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 4.82% | 3,783,994 | 103.76M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 2,487,758 | 68.21M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 2,020,869 | 55.41M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.04% | 1,603,138 | 43.96M | Sep 29, 2026 |
| Vanguard Explorer Fund | 1.84% | 1,447,608 | 39.69M | Jul 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.60% | 1,254,603 | 34.40M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JIMENEZ FREDDY A | General Counsel | Sale | Dec 3, 2025 | 30,796 |
| MARTIN SAMUEL BATES | Chief Financial Officer | Conversion of Exercise of derivative security | Jan 1, 2026 | 32,942 |
| PEPIN RONALD A | Officer | Conversion of Exercise of derivative security | Dec 14, 2025 | 20,097 |
| WRIGHT RICHARD M | Former | Conversion of Exercise of derivative security | Nov 12, 2025 | 20,833 |
